Kanada - englanti - Health Canada

pharmascience inc - piroxicam - capsule - 10mg - piroxicam 10mg - other nonsteroidal antiimflammatory agents

Kanada - englanti - Health Canada

ratiopharm inc division of teva canada limited - diltiazem hydrochloride - capsule (controlled-delivery) - 120mg - diltiazem hydrochloride 120mg - miscellaneous calcium-channel blocking agents

Kanada - englanti - Health Canada

ratiopharm inc division of teva canada limited - diltiazem hydrochloride - capsule (controlled-delivery) - 180mg - diltiazem hydrochloride 180mg - miscellaneous calcium-channel blocking agents

Kanada - englanti - Health Canada

ratiopharm inc division of teva canada limited - diltiazem hydrochloride - capsule (controlled-delivery) - 240mg - diltiazem hydrochloride 240mg - miscellaneous calcium-channel blocking agents

Kanada - englanti - Health Canada

ratiopharm inc division of teva canada limited - diltiazem hydrochloride - capsule (controlled-delivery) - 300mg - diltiazem hydrochloride 300mg - miscellaneous calcium-channel blocking agents

Armenia - englanti - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sandoz private limited - reserpine, dihydralazine sulfate, hydrochlorothiazide - tablets - 0,1g+10mg+10mg

Yhdysvallat - englanti - NLM (National Library of Medicine)

gland pharma limited - temsirolimus (unii: 624kn6gm2t) (temsirolimus - unii:624kn6gm2t) - temsirolimus injection is indicated for the treatment of advanced renal cell carcinoma. temsirolimus injection is contraindicated in patients with bilirubin >1.5×uln [see warnings and precautions (5.2) ]. risk summary based on findings in animal studies and its mechanism of action, temsirolimus can cause fetal harm when administered to a pregnant woman [see clinical pharmacology (12.1)]. although there are no data on the use of temsirolimus injection in pregnant women, there are limited data on the use of sirolimus, the active metabolite of temsirolimus, during pregnancy; however, these data are insufficient to inform a drug-associated risk of adverse developmental outcomes. in animal reproductive studies, oral daily administration of temsirolimus to pregnant rats and rabbits during organogenesis caused adverse embryo-fetal effects at approximately 0.04 and 0.12 times the auc in patients at the recommended dose, respectively (see data). advise pregnant women of the potential hazard to a fetus. the est

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sm pharmaceuticals sdn. bhd. - insulin glargine__ -

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sm pharmaceuticals sdn. bhd. - insulin glargine -

Yhdysvallat - englanti - NLM (National Library of Medicine)

gtg wellness co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - sanitizer ■ to help reduce bacteria on skin.